Acadia Healthcare (NASDAQ:ACHC – Free Report) had its price objective trimmed by Barclays from $76.00 to $43.00 in a report published on Friday morning,Benzinga reports. The firm currently has an overweight rating on the stock.
Several other research firms have also recently commented on ACHC. Deutsche Bank Aktiengesellschaft raised their target price on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday. Royal Bank of Canada cut their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday, November 18th. KeyCorp assumed coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $79.67.
Check Out Our Latest Stock Analysis on ACHC
Acadia Healthcare Trading Down 0.9 %
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.91 EPS. Sell-side analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.
Institutional Investors Weigh In On Acadia Healthcare
Institutional investors and hedge funds have recently modified their holdings of the stock. Harbor Capital Advisors Inc. acquired a new stake in Acadia Healthcare during the 2nd quarter worth about $800,000. TCW Group Inc. lifted its position in shares of Acadia Healthcare by 63.8% in the 2nd quarter. TCW Group Inc. now owns 62,888 shares of the company’s stock valued at $4,247,000 after acquiring an additional 24,487 shares in the last quarter. SG Americas Securities LLC boosted its stake in Acadia Healthcare by 435.6% in the 2nd quarter. SG Americas Securities LLC now owns 18,227 shares of the company’s stock worth $1,231,000 after purchasing an additional 14,824 shares during the period. Principal Financial Group Inc. raised its stake in Acadia Healthcare by 19.4% during the 2nd quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock valued at $43,463,000 after purchasing an additional 104,359 shares during the period. Finally, LMR Partners LLP purchased a new stake in shares of Acadia Healthcare in the third quarter valued at $1,616,000.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also
- Five stocks we like better than Acadia Healthcare
- How to Invest in Small Cap Stocks
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Breakout Stocks: What They Are and How to Identify Them
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- What Are Dividend Contenders? Investing in Dividend Contenders
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.